Glioblastoma Clinical Trials
Glioblastoma clinical trials evaluate new drugs, immunotherapies, radiation approaches, and combination treatments for glioblastoma. Corterve aggregates actively recruiting Glioblastoma studies from the public ClinicalTrials.gov registry so you can browse them by location and eligibility. Many oncology trials enroll patients at different stages of disease, including newly diagnosed and previously treated. This is general information, not medical advice — review any study with your oncology care team before enrolling.
Recruiting Glioblastoma studies
- Tear Fluid for the Detection of Tumor-associated Extracellular Vesicles in Glioblastoma PatientsNCT07775534NACity of Hope Medical CenterGlioblastomaDuarte, California
- Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma CellsNCT06059690PHASE1, PHASE2Jonsson Comprehensive Cancer CenterGlioblastoma MultiformeLos Angeles, California
- Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma MultiformeNCT00083512National Cancer Institute (NCI)Glioblastoma MultiformeBethesda, Maryland
- Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIINCT07326566PHASE2Black Diamond Therapeutics, Inc.Glioblastoma (GBM)Birmingham, Alabama
- Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsNCT06814496PHASE1, PHASE2University of ArizonaMelanomaGilbert, Arizona
- TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly GliomaNCT07862647PHASE1Alpheus Medical, Inc.Glioblastom WHO Grade 4Buffalo, New York
- Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMNCT05902169PHASE3CarTheraGlioblastomaPhoenix, Arizona
- Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CareNCT07195591PHASE3GT Medical Technologies, Inc.GlioblastomaScottsdale, Arizona
- Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed GlioblastomaNCT06991101PHASE2Baptist Health South FloridaGlioblastomaMiami, Florida
- A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaNCT03970447PHASE2, PHASE3Global Coalition for Adaptive ResearchGlioblastomaBirmingham, Alabama
- GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 AstrocytomaNCT07301268PHASE2Mayo ClinicGlioblastoma, IDH-WildtypeRochester, Minnesota
- Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentNCT05432804PHASE1, PHASE2National Cancer Institute (NCI)Recurrent Glioblastoma, IDH-WildtypePhoenix, Arizona
Glioblastoma trials by state
Glioblastoma trials by metro
Frequently asked questions
- How do I find recruiting Glioblastoma clinical trials?
- Browse the actively recruiting Glioblastoma studies listed on this page, or take an assessment to see trials you may qualify for based on your profile.
- Are Glioblastoma clinical trials free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- Who can take part in a Glioblastoma clinical trial?
- Each study has its own eligibility criteria (for example age, disease stage, and prior treatments). This page is general information and not medical advice; discuss any specific trial with your healthcare provider to confirm whether it is appropriate for you.